Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > we must be in one corner at fda

<< Previous

Bullboard Posts

Next >>

Post by m8magicon Nov 02, 2023 9:15am

335 Views

Post# 35713100

we must be in one corner at fda

this could be us soon.they got less results then us..TIVDAK has been used in practice since phase 2 trials led to accelerated approval by the FDA in the U.S....its an interesting read,,https://www.foxnews.com/health/cervical-cancer-drug-increased-survival-rate-30-percent-chemotherapy-game-changer

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments